Asia Pacific Pharmaceutical Glass Packaging Market Size was valued at USD 16.2 Billion in 2022. The Pharmaceutical Glass Packaging industry is projected to grow from USD 17.36 Billion in 2023 to USD 30.28 Billion by 2032, exhibiting a compound yearly growth rate (CAGR) of 7.20% during the forecast period (2024 - 2032). The adoption of new glass types in order to reduce product contamination is the major market driver driving the Pharmaceutical Glass Packaging market in Asia Pacific. The pharmaceutical industry is growing rapidly due to the exponential growth of population, rising spending on public healthcare systems, and surging awareness of health.
Source: The Primary Research, Secondary Research, MRFR Database and Analyst Review
The Asia Pacific Pharmaceutical Glass Packaging market CAGR is expanding due to the growing pharmaceutical industry in developing economies. The emerging economies in the region have been witnessing an increase in pharmaceutical consumption and manufacturing owing to different factors like rising population and growing healthcare requirements, leading to an increased demand for pharmaceutical products. Moreover, the improving healthcare infrastructure, rising income levels, and surging middle-class population help in broadening the pharmaceutical sector in the Asia Pacific region. As a result, there is an increased demand for high-quality packaging solutions for ensuring the efficacy, safety, and integrity of pharmaceutical products. Glass packaging has become a preferred option for pharmaceuticals because of its inert nature, minimizing the risk of chemical reactions between the container and contents, as it provides prime barrier features by protecting the drugs from oxygen, moisture and other external factors which can deteriorate their stability. Glass packaging is eco-friendly and recyclable which aligns with the global sustainability trend.
Furthermore, the advancements in glass manufacturing technologies have resulted in the development of new and innovative packaging designs catering to the demands of pharmaceutical industries. This improves the usability, functionality, and aesthetics of glass packaging, hence boosting market growth. Moreover, transparency is provided by the glass packaging as it allows for easy inspection of content, which is essential for making sure that the product aligns with the regulatory standards. Also, the rising preference for generic drugs and biopharmaceuticals in emerging countries is boosting the demand for high-quality packaging solutions as they require stringent storage conditions. The increasing prevalence of chronic diseases, expanding pharmaceutical distribution networks, and growing healthcare lead to market growth. Thus driving the Pharmaceutical Glass Packaging market revenue.
SGD Pharma, which had successfully run a campaign using 20% post-consumer recycled (PCR) glass at its Zhanjiang plant in China in September of the Year 2024. The purpose of this action is to lessen carbon footprints and minimize reliance on virgin raw materials in accordance with the global sustainability initiatives of SGD Pharm. This particular initiative not only provides solutions to the environmental concerns, but it also tackles the growing demand for eco-friendly packing in the cosmetics and pharmaceutical market.
The Asia Pacific Pharmaceutical Glass Packaging market segmentation, based on product, includes Vials & Ampoules, Bottles, Cartridges and Syringes. The bottles segment dominated the market due to its chemical inertness, superior protective, and rigidity qualities. Moreover, the bottles have attained preference in the packaging of solid and liquid pharmaceutical preparations like capsules, syrups, tablets, and ophthalmic products. On the other hand, the vials & ampoules category is expected to grow at a rapid CAGR as the entry of atmospheric gases like oxygen and CO2 is prevented in glass vials. Vials are inert, hence preventing the product from undergoing oxidation or hydrolysis.
Figure 1: Asia Pacific Pharmaceutical Glass Packaging Market, by Product, 2023 & 2032 (USD Billion)
Source: The Primary Research, Secondary Research, MRFR Database and Analyst Review
The Asia Pacific Pharmaceutical Glass Packaging market segmentation, based on drug type, includes Generic, Branded, and Biologic. The generic category dominates the market. Generic drugs are comparatively of low price than branded drug products having similar composition. There is an increase in the promotion of using generic drugs as per the initiatives taken by the government. Further, the biological category is anticipated to grow due to its high effectiveness in the treatment of chronic and autoimmune diseases.
The growth of pharmaceutical industries globally has resulted in a boom in demand for Pharmaceutical Glass Packaging in Asia Pacific in recent years. The increasing healthcare expenditure, fast urbanization, and rising pharmaceutical manufacturing activities in the countries of this region drive the demand for high-quality packaging solutions. Also, the rising prevalence of chronic diseases and the region's growing population drive the market growth. Technological advancements in glass manufacturing processes are improving the functionality and sustainability of glass packaging solutions and meeting the surging demands of the market. Moreover, the regulatory initiatives that promote domestic production and sustainability are also boosting market growth. Pharmaceutical glass packaging is opted for its inertness, non-reactivity, and impermeability to gases, ensuring the preservation of product efficacy and safety.
Figure 2: ASIA PACIFIC PHARMACEUTICAL GLASS PACKAGING MARKET SHARE BY REGION 2022 (USD Billion)
Source: The Primary Research, Secondary Research, MRFR Database and Analyst Review
Leading market players are investing heavily in the research and development in order to extend their product lines, which will help the Pharmaceutical Glass Packaging market grow even more. Market participants are also undertaking different strategic activities to extend their footprint, with important market developments including contractual agreements, new product launches, mergers and acquisitions, higher investments, and collaboration with the other organizations. To expand and sustain in a more competitive and rising market climate, the Pharmaceutical Glass Packaging industry must offer cost-effective items.
Peime players in the Pharmaceutical Glass Packaging market are trying to increase the market demand by investing in the research and development operations, including Saint-Gobain, Owens-Illinois, Inc., Amcor plc, Ardagh Group S.A., HEINZ-GLAS GmbH & Co. KGaA, BA GLASS GROUP, Bormioli Rocco S.p.A, Gerresheimer AG, Hindustan National Glass & Industries Limited. and KOA GLASS CO. LTD.
March 2021: A subsidiary of The Oneida Group, Anchor Hocking Glass Company's Monaca, Pennsylvania glass factory, was acquired by Stoelzle Glass Group. This acquisition helped the company start its seventh glass plant in the US and first outside Europe.
In the year of 2023 when Gerresheimer AG started the cooperation with SCHOTT AG and Stevanato Group titled “Alliance for RTU” Ready-To-Use for pharmaceutical packaging. This alliance aims at enhancing efficiency of the ready-to-use/pre-sterilized packaging systems in Asia where pharmaceutical companies’ drug safety and delivery systems would be made perfect by this collaboration in the pharmaceutical sector.
In October of the year 2023 Nippon Glass enlarged its activities in the territory of China by purchasing one of the local pharmaceutical glass packaging manufacturers. Such a step emphasizes the growing weight of the Chinese market for foreign companies as it houses a huge pharmaceutical market and a shift towards new safe packaging materials.
According to the current estimates, as of October 2023, Gerresheimer AG, one of the leaders in the industry of pharmaceutical glass containers, managed to expand its constructor production facilities in China and reinforce its position on the fast-evolving market. Also, in Dec 2023, a Japanese company called Nipro Corporation launched the production of avant-garde glass containers for biopharmaceuticals, claiming the attention to glass packing innovation.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 16.2 Billion |
| Market Size 2023 | USD 17.36 Billion |
| Market Size 2032 | USD 30.28 Billion |
| Compound Annual Growth Rate (CAGR) | 7.20% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2019- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, Drug Type, and Region |
| Region Covered | Asia Pacific |
| Countries Covered | China, Japan, India, Australia, South Korea, Indonesia, Thailand, Vietnam, Malaysia, Singapore, Rest of Asia-Pacific |
| Key Companies Profiled | Saint-Gobain, Owens-Illinois, Inc., Amcor plc, Ardagh Group S.A., HEINZ-GLAS GmbH & Co. KGaA, BA GLASS GROUP, Bormioli Rocco S.p.A, Gerresheimer AG, Hindustan National Glass & Industries Limited. and KOA GLASS CO. LTD. |
| Key Market Opportunities | ·        Growing adoption of biopharmaceuticals and specialty drugs. |
| Key Market Dynamics | ·        Rapid growth of pharmaceutical industries. ·        Requirement for stringent regulations. |
Frequently Asked Questions (FAQ) :
The Asia Pacific Pharmaceutical Glass Packaging market size valued at USD 17.36 Billion in 2023.
The market is foreseen to grow at the CAGR of 7.20% throughout the forecast period, 2024-2032.
The key players in the market are Saint-Gobain, Owens-Illinois, Inc., Amcor plc, Ardagh Group S.A., HEINZ-GLAS GmbH & Co. KGaA, BA GLASS GROUP, Bormioli Rocco S.p.A, Gerresheimer AG, Hindustan National Glass & Industries Limited. and KOA GLASS CO. LTD.
The bottles category dominates the market in 2023.
The generic drugs category had the largest share in the market.
Assistant Manager - Research High acumen in analyzing complex macro & micro markets with more than 6 years of work experience in the field of market research. by implementing her analytical skills in forecasting and estimation into market research reports, she has expertise in packaging, construction, and equipment domains. she handles a team size of 20-25 resources and ensures smooth running of the projects, associated marketing activities, and client servicing.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
